BORA PHARMACEUTICALS LTD (6472) - Total Liabilities

Latest as of March 2026: NT$28.70 Billion TWD ≈ $904.30 Million USD

Based on the latest financial reports, BORA PHARMACEUTICALS LTD (6472) has total liabilities worth NT$28.70 Billion TWD (≈ $904.30 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 6472 net assets growth trend to track the company's year-over-year net asset growth rate.

BORA PHARMACEUTICALS LTD - Total Liabilities Trend (2019–2025)

This chart illustrates how BORA PHARMACEUTICALS LTD's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of BORA PHARMACEUTICALS LTD to measure how efficiently the company converts operating cash flow to free cash.

BORA PHARMACEUTICALS LTD Competitors by Total Liabilities

The table below lists competitors of BORA PHARMACEUTICALS LTD ranked by their total liabilities.

Company	Country	Total Liabilities
Cyrela Brazil Realty S.A. Empreendimentos e Participações SA:CYRE3	Brazil	R$13.46 Billion
Staidson Beijing Biopharma SHE:300204	China	CN¥486.07 Million
Suzhou Douson Drilling & Production Equipment Co Ltd SHG:603800	China	CN¥1.72 Billion
Wuxi Best Precision Machinery Co Ltd SHE:300580	China	CN¥562.67 Million
Healthcare Services Group Inc NASDAQ:HCSG	USA	$301.08 Million
Domain Holdings Australia Limited F:3DH	Germany	€369.87 Million
Hangzhou DPtech Technologies Co Ltd SHE:300768	China	CN¥473.17 Million
PagSeguro Digital Ltd NYSE:PAGS	USA	$59.92 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down BORA PHARMACEUTICALS LTD's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BORA PHARMACEUTICALS LTD market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.38	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.97	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BORA PHARMACEUTICALS LTD's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BORA PHARMACEUTICALS LTD (2019–2025)

The table below shows the annual total liabilities of BORA PHARMACEUTICALS LTD from 2019 to 2025.

Year	Total Liabilities	Change
2025-09-30	NT$27.24 Billion ≈ $858.27 Million	-10.94%
2024-09-30	NT$30.59 Billion ≈ $963.67 Million	+130.22%
2023-09-30	NT$13.29 Billion ≈ $418.59 Million	-24.60%
2022-09-30	NT$17.62 Billion ≈ $555.15 Million	+317.57%
2021-09-30	NT$4.22 Billion ≈ $132.95 Million	-7.04%
2020-09-30	NT$4.54 Billion ≈ $143.02 Million	+162.56%
2019-09-30	NT$1.73 Billion ≈ $54.47 Million	--

About BORA PHARMACEUTICALS LTD

TW:6472 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$1.54 Billion

NT$48.72 Billion TWD

Market Cap Rank

#7011 Global

#208 in Taiwan

Share Price

NT$382.50

Change (1 day)

+2.27%

52-Week Range

NT$336.00 - NT$792.00

All Time High

NT$940.36